Меню
Идёт набор NCT06938971

Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH)

Без фазы С лечением Metastatic Colorectal Cancer (mCRC)

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Exercise training.
Кому может быть актуально
Состояния в реестре: Metastatic Colorectal Cancer (mCRC). Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Дания
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Effects of Exercise Training on Health-related Quality of Life in Patients With Unresectable Metastatic Colorectal Cancer: A Multi-center Randomized Controlled Trial

Обзор

The primary objective of this trial is to compare the effects of 18 weeks structured exercise training versus on control on healt-related quality of life in patients with mCRC undergoing first-line chemotherapy.

Вмешательства

  • Другое Exercise training
    Participants allocated to the exercise intervention group will receive standard care plus an exercise intervention. The exercise intervention will consist moderate-to-high intensity supervised and unsupervised home-based exercise training (bicyling, walking, or running) 5 times/week for 18 weeks.

Первичные конечные точки

  • Health-related quality of life [Срок оценки: Every 3 weeks from randomization until post-intervention (18 weeks), withdrawal of consent to participate, or death (whichever occurs first)]
Вторичные конечные точки (12)
  • Health-related quality of life [Срок оценки: Randomization and 3, 6, 9, 12, 15, and 18 weeks after randomization or until withdrawal of consent to participate, or death (whichever occurs first). Followed-up at 36, 52, 104, and 156 weeks after randomization.]
  • Colorectal cancer-specific symptoms [Срок оценки: Randomization and 3, 6, 9, 12, 15, and 18 weeks after randomization or until withdrawal of consent to participate, or death (whichever occurs first). Followed-up at 36, 52, 104, and 156 weeks after randomization.]
  • Cancer related fatigue [Срок оценки: Randomization and 3, 6, 9, 12, 15, and 18 weeks after randomization or until withdrawal of consent to participate, or death (whichever occurs first). Followed-up at 36, 52, 104, and 156 weeks after randomization.]
  • Patient-reported symptomatic adverse events [Срок оценки: 7 days after every second cycle of treatment, starting from the second cycle. Each cycle is 2-3 weeks, depending on the regimen.]
  • Serious adverse events [Срок оценки: From randomization to 20 weeks after randomization]
  • Unscheduled hospitalizations [Срок оценки: From randomization to 20 weeks after randomization]
  • Dose delays of chemotherapy [Срок оценки: From randomization to 20 weeks after randomization]
  • Dose reductions of chemotherapy [Срок оценки: From randomization to 20 weeks after randomization]
  • Discontinuation of chemotherapy [Срок оценки: From randomization to 20 weeks after randomization]
  • Estimated maximal oxygen uptake [Срок оценки: Randomization, 18 weeks after randomization]
  • Estimated maximal oxygen uptake [Срок оценки: Randomization, 18 weeks after randomization]
  • Hand-grip strength [Срок оценки: Randomization, 18 weeks after randomization]

Критерии участия

Критерии включения

\- Adults (≥18 years of age) schduled to undergo first-line chemotherapy for the treatment of metastatic colorectal cancer.

Критерии исключения

  • Pregnancy.
  • A life expectancy of < 6 months.
  • Absolute contraindications to maximal exercise, as per the recommendations by the Danish Society of Cardiology.
  • ECOG (Eastern Cooperative Oncology Group) performance status > 2.
  • Inability to understand the Danish or English language.
  • Engagement in structured moderate-to-high aerobic exercise training for >30 min >1 times/week for the past 3 months at the time of inclusion.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Поддерживающая терапия

Центры проведения

Дания · 4 центра
  • Centre for Physical Activity Research, Copenhagen Univerisity Hospital - Rigshospitalet — Copenhagen
  • Herlev and Gentofte Hospital — Herlev
  • North Zealand University Hospital, Hillerød — Hillerød
  • Zealand University Hospital, Roskilde — Roskilde

Идентификаторы

NCT: NCT06938971 · Exercise mCRC

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗